Market Overview

ICYMI: Beleaguered Biotech, Funko Shares In A Funk, And Auto Stocks

Share:
ICYMI: Beleaguered Biotech, Funko Shares In A Funk, And Auto Stocks
Related FNKO
Stifel: Funko's Q1 Impresses Despite Toys R Us Liquidation
The Week Ahead: Tesla And Apple Earnings, Dropbox Quiet Period Expires, Fed Rate Decision And More
Related NVAX
Benzinga's Daily Biotech Pulse: ARMO Skyrockets On Eli Lilly Deal, Akcea Meets FDA Panel, vTv Alzheimer's Trial Results
Benzinga's Daily Biotech Pulse: Transenterix Rises, Mylan Earnings, Deutsche Bank Conference Underway

In case you missed it, here are some of Benzinga's top stories from Tuesday, Dec. 19, 2017.

No Fun For Funko Investors

In “Funko Shares Plunge To All-Time Low After BMO Downgrade,” Shanthi Rexaline discusses the analyst downgrade and resulting downside in shares of Funko, Inc (NASDAQ: FNKO) as they fell to the lowest level since their recent IPO.

Morgan Stanley On Autos: Expect Autonomous 'Noise,' 'Idiosyncratic' Returns"

From Fiat Chrysler Automobiles (NYSE: FCAU) to Avis Budget Group, Inc (NASDAQ: CAR), learn which manufacturers and suppliers Morgan Stanley likes best heading into the new year.

Related Link: ICYMI: Longfin, On Track Innovations Gets The Bitcoin Bounce, BlackBerry's Bull Case, An Under-The-Radar Story In The Semiconductor Space

Novavas: Biotech Stock’s Turnaround Hits A Snag

Jayson Derrick, in “More Bad News For Novavax: A Citi Downgrade,” explains how Novavax, Inc (NASDAQ: NVAX) has struggled to come back from a devastating clinical trial failure back in late 2016. See why Citi analysts felt like the stock is no longer a Buy.

Posted-In: BZ ICYMINews Media Reviews Best of Benzinga

 

Related Articles (CAR + FCAU)

View Comments and Join the Discussion!